alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 509 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 509

 To amend the Internal Revenue Code of 1986 to increase the deduction 
                   allowed for student loan interest.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 22, 2015

 Mr. Rangel (for himself, Mr. Gutieerrez, Mr. Cartwright, Mr. Conyers, 
  Mr. Hinojosa, Mr. Larson of Connecticut, Ms. Lee, Mr. Loebsack, Mr. 
Lowenthal, Mr. Quigley, Mr. McDermott, Ms. Meng, Mr. Vargas, Ms. Wilson 
of Florida, Ms. Brown of Florida, Mr. Al Green of Texas, Mr. Hastings, 
 Mr. Honda, Mrs. Kirkpatrick, Mr. McNerney, Ms. Moore, Mr. Nolan, Mr. 
Perlmutter, Mr. Peterson, Ms. Sewell of Alabama, Mr. Fattah, Ms. Eddie 
Bernice Johnson of Texas, Ms. Bordallo, Mr. Grijalva, and Ms. Plaskett) 
 introduced the following bill; which was referred to the Committee on 
                             Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to increase the deduction 
                   allowed for student loan interest.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Student Loan Interest Deduction Act 
of 2015''.

SEC. 2. INCREASE IN DEDUCTION FOR STUDENT LOAN INTEREST.

    (a) Increase in Dollar Limitation and Repeal of Limitation Based on 
Income.--Section 221(b) of the Internal Revenue Code of 1986 is amended 
to read as follows:
    ``(b) Maximum Deduction.--The deduction allowed by subsection (a) 
for the taxable year shall not exceed $5,000 ($10,000 in the case of a 
joint return).''.
    (b) Conforming Amendments.--Section 221 of such Code is amended by 
striking subsections (e) and (f) (relating to special rules and 
inflation adjustments, respectively) and inserting the following new 
subsection:
    ``(e) Denial of Double Benefit.--No deduction shall be allowed 
under this section for any amount for which a deduction is allowable 
under any other provision of this chapter.''.
    (c) Effective Date.--The amendments made by this section shall 
apply to taxable years beginning after the date of the enactment of 
this Act.
                                 <all>
```
# L_2005042EN.01002901.xml

| 12.2.2005 | EN | Official Journal of the European Union | L 42/29 |
| --- | --- | --- | --- |

12.2.2005

EN

Official Journal of the European Union

L 42/29

---

COMMISSION DECISION

of 11 February 2005

on the continuation in the year 2005 of Community comparative trials and tests on propagating and planting material of Prunus domestica under Council Directive 92/34/EEC started in 2002

(2005/125/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 92/34/EEC of 28 April 1992 on the marketing of fruit plant propagating material and fruit plants, intended for fruit production (1),

Having regard to Commission Decision 2001/896/EC of 12 December 2001 setting out the arrangements for Community comparative trials and tests on propagating and planting material of fruit plants under Council Directive 92/34/EEC (2), and in particular Article 2 thereof,

Whereas:

| (1) | Decision 2001/896/EC sets out the arrangements for the comparative trials and tests to be carried out under Directive 92/34/EEC as regards Prunus domestica from 2002 to 2006. |
| --- | --- |

(1)

Decision 2001/896/EC sets out the arrangements for the comparative trials and tests to be carried out under Directive 92/34/EEC as regards Prunus domestica from 2002 to 2006.

| (2) | Tests and trials carried out in 2002 to 2004 should be continued in 2005, |
| --- | --- |

(2)

Tests and trials carried out in 2002 to 2004 should be continued in 2005,

HAS DECIDED AS FOLLOWS:

Sole Article

Community comparative trials and tests which began in 2002 on propagating and planting material of Prunus domestica shall be continued in 2005 in accordance with Decision 2001/896/EC.

Done at Brussels, 11 February 2005.

For the Commission

Markos KYPRIANOU

Member of the Commission

---

(1)  
  OJ L 157, 10.6.1992, p. 10. Directive as last amended by Directive 2003/111/EC (OJ L 311, 27.11.2003, p. 12).

1

(2)  
  OJ L 331, 15.12.2001, p. 95.

2

---
Exhibit
      14.1


**XIOM
      Corp.**





**CODE
      OF ETHICS**


**FOR**


**DIRECTORS,
      CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, CHIEF ACCOUNTING OFFICER
      OR
      CONTROLLER AND PERSONS PERFORMING**


**SIMILAR
      FUNCTIONS**





*GENERAL
      PHILOSOPHY*


The
      honesty, integrity and sound judgment of XIOM Corp.’s (“XIOM” or the “Company”)
      Chief Financial Officer, Chief Accounting Officer or Controller and persons
      performing similar functions (collectively the “Principal Officers”) is
      fundamental to our reputation and success. The professional and ethical conduct
      of the Principal Officers is essential to the proper functioning and success
      of
      XIOM.





*APPLICABILITY*


This
      Code
      of Ethics shall apply to XIOM’s Directors and Principal Officers.





*STANDARDS
      OF CONDUCT*


To
      the
      best of their knowledge and ability, the Directors and Principal Officers
      shall:





o
            act
                with honesty and integrity, including the ethical handling of actual
                or
                apparent conflicts of interest between personal and professional
                relationships;


o
            provide
                full, fair, accurate, timely, and understandable disclosure in reports
                and
                documents that XIOM files with, or submits to, the Securities and
                Exchange
                Commission (“Commission”) and in other public communications made by
                XIOM;


o
            comply
                with applicable governmental laws, rules and
                regulations;


o
            promote
                the prompt internal reporting of violations of this Code of Ethics
                to
                XIOM's board of directors and outside legal
                counsel;


o
            respect
                the confidentiality of information acquired in the course of
                employment;


o
            maintain
                the skills necessary and relevant to XIOM's needs;
                and


o
            proactively
                promote ethical and honest behavior among employees of XIOM and its
                subsidiaries.





All
      Directors and Principal Officers are expected to adhere to the XIOM Code of
      Ethics. Any violation of this Code of Ethics will be subject to appropriate
      discipline, up to and including dismissal from the Company and prosecution
      under
      the law. The Board of Directors shall have responsibility for administration
      of
      this Code of Ethics and shall have the sole and absolute discretionary authority
      to approve any deviation or waiver from this Code of Ethics for Directors and
      Principal Officers. In the event that a waiver of, modification of and/or change
      to this Code of Ethics is approved and granted, then the notice of the waiver,
      modification, and/or change shall be disclosed as may be required by SEC rules
      or the rules of any exchange on which the securities of the Company are then
      trading.
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                         PURSUANT TO SECTION 302 OF THE
                           SARBANES-OXLEY ACT OF 2002

I, James E. Solomon, certify that:

1. I have reviewed this report on Form 10-QSB of TechAlt, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

      a)  Designed  such  disclosure  controls  and  procedures,  or caused such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

      c)  Disclosed  in this  report  any  change in the  registrant's  internal
control over financial  reporting  that occurred  during the  registrant's  most
recent fiscal quarter that has materially  affected,  or is reasonably likely to
materially affect, the registrant's  internal control over financial  reporting;
and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

      a) All significant  deficiencies and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

      b) Any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's  internal control over
financial reporting.


Dated: November 15, 2004               /s/ James E. Solomon
                                       -----------------------------------------
                                       James E. Solomon
                                       President and Chief Executive Officer
GRAND VENEZIA COA, INC., Appellant/Petitioner(s), v. CLEARWATER CAY COMMUNITY DEVELOPMENT DISTRICT, et al., Appellee/Respondent(s).

CASE NO.: 2D17-3039

District Court of Appeal of Florida, Second District.

January 03, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
UNITED STATES BANKRUPTCY COURT 

SOUTHERN DISTRICT OF FLORIDA 

In re: 

JULIA RODRIGUEZ SANCHEZ 

Debtor. 

_____________________________________/

Case Number 21-21561-BKC-AJC 

Chapter 7 

SUPPLEMENTAL FEE DISCLOSURE 

 Counsel for the Debtor(s), Kingcade & Garcia, P.A., pursuant to 11 U.S.C. § 329 and 

Rule 2016 of the Federal Rules of Bankruptcy Procedure, hereby files this Supplemental Fee 

Disclosure. 

 1. The Debtor has requested and believes that the following services, which are not 

contemplated by the original fee agreement between the Debtor and the attorney for the Debtor, 

are reasonable and necessary: Motions to Redeem Collateral City Furniture Ashley Furniture.

2. For these services, counsel for the Debtor(s), Kingcade & Garcia, P.A., has 

received a fee of $950.00 and costs of $50.00. Kingcade & Garcia, P.A. has not agreed to share 

the above – disclosed compensation with person(s) who are not members or associates of 

Kingcade & Garcia, P.A. 

CERTIFICATE OF SERVICE 

I HEREBY CERTIFY that a true and correct copy of the foregoing was sent, via CM/ 

ECF, on January 14, 2021 to the Assistant United States Trustee. 

CERTIFICATE PURSUANT TO 

LOCAL RULE 9011-4(B) 

I HEREBY CERTIFY that I 

am admitted to the Bar of the 

United States District Court for 

the Southern District of Florida 

and I am in compliance with the 

additional qualifications to 

practice in this Court set forth in 

Local Rule 2090-1(A). 

KINGCADE & GARCIA, P.A 

Counsel for the Debtor 

Kingcade Building 

1370 Coral Way ▪ Miami, Florida 33145-2960 

WWW.MIAMIBANKRUPTCY.COM

Telephone: 305-285-9100 ▪ Facsimile: 305-

285-9542 

/S/Jessica L. McMaken for_______ 

X Timothy S. Kingcade, Esq., FBN 082309 

□ Wendy Garcia, Esq., FBN 0865478 

□ Jessica L. McMaken, Esq., FBN 580163 

Case 21-21561-AJC Doc 15 Filed 01/14/22 Page 1 of 1
STATE EX REL. Carter Vincent ANDERSON v. STATE of Louisiana

NO. 2017-KH-1530

Supreme Court of Louisiana.

August 3, 2018

Denied.
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D17-2483

_____________________________

WAYNE PAUL MANNING,

Appellant,

v.

JULIE L. JONES, Secretary, 

Florida Department of 

Corrections,

Appellee.

___________________________

On appeal from the Circuit Court for Santa Rosa County.

John F. Simon, Judge.

March 15, 2018

PER CURIAM.

AFFIRMED.

ROBERTS, ROWE, and MAKAR, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________

Wayne Paul Manning, pro se, Appellant.
2

Pamela Jo Bondi, Attorney General, Thomas H. Duffy and 

Kenneth S. Steely, Assistant Attorneys General, Tallahassee, for 

Appellee.
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 525 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 525

To amend the Controlled Substances Act to exclude industrial hemp from 
          the definition of marihuana, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 26, 2015

  Mr. Massie (for himself, Mr. Polis, Mr. Hanna, Mr. Blumenauer, Mr. 
  Schrader, Mr. Rohrabacher, Ms. Bonamici, Mr. Amash, Mr. Cohen, Mr. 
DeFazio, Ms. DeGette, Ms. DelBene, Mr. Ellison, Mr. Farr, Ms. Gabbard, 
Ms. Norton, Mr. Honda, Mr. Clay, Ms. Lee, Mr. McClintock, Ms. McCollum, 
Mr. O'Rourke, Mr. Peterson, Ms. Pingree, Mr. Pocan, Mr. Cartwright, Ms. 
Schakowsky, Mr. Ryan of Ohio, Mr. Yarmuth, Ms. DeLauro, Mr. Welch, Mr. 
Buck, Mr. Labrador, Mr. Cramer, Mr. Grijalva, Mr. Barr, Mr. Zinke, Mr. 
   Young of Alaska, Mr. Walz, Mr. Young of Indiana, Mr. Stivers, Mr. 
Nadler, Mr. McDermott, Ms. Lofgren, Mr. Perry, Mr. Yoho, Mr. Mulvaney, 
and Mr. Jones) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
To amend the Controlled Substances Act to exclude industrial hemp from 
          the definition of marihuana, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Industrial Hemp Farming Act of 
2015''.

SEC. 2. EXCLUSION OF INDUSTRIAL HEMP FROM DEFINITION OF MARIHUANA.

    Section 102 of the Controlled Substances Act (21 U.S.C. 802) is 
amended--
            (1) in paragraph (16)--
                    (A) by striking ``(16) The'' and inserting 
                ``(16)(A) The''; and
                    (B) by adding at the end the following:
            ``(B) The term `marihuana' does not include industrial 
        hemp.''; and
            (2) by adding at the end the following:
            ``(57) The term `industrial hemp' means the plant Cannabis 
        sativa L. and any part of such plant, whether growing or not, 
        with a delta-9 tetrahydrocannabinol concentration of not more 
        than 0.3 percent on a dry weight basis.''.

SEC. 3. INDUSTRIAL HEMP DETERMINATION.

    Section 201 of the Controlled Substances Act (21 U.S.C. 811) is 
amended by adding at the end the following:
    ``(i) Industrial Hemp Determination.--If a person grows or 
processes Cannabis sativa L. for purposes of making industrial hemp in 
accordance with State law, the Cannabis sativa L. shall be deemed to 
meet the concentration limitation under section 102(57).''.
                                 <all>
```
Exhibit 23

 

**CONSENT OF INDEPENDENT AUDITORS**

 

We consent to the incorporation by reference in the Registration Statements (Form S-4 No. 333-71510 and Form S-4 No. 333-103362) of IMC Global Inc. and in the related Prospectuses of our report, dated January 27, 2003, except for Note 5, as to which the date isFebruary 21, 2003, with respect to the consolidated financial statements of IMC Phosphates Company included in this Annual Report (Form 10-K) for the year ended December 31, 2002.

**

Ernst & Young LLP

Chicago, IllinoisMarch 17, 2003

 

*Return to IMC Phosphates Company Form 10-K*
<page> EXHIBIT 32.02



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Morgan Stanley Spectrum
Currency L.P. (the ?Partnership?) on Form 10-Q for the period
ended June 30, 2006 as filed with the Securities and Exchange
Commission on the date hereof (the ?Report?), I, Kevin Perry,
Chief Financial Officer, Demeter Management Corporation, the
general partner of the Partnership, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:
(1)	The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.









By:   /s/ Kevin Perry

Name:		Kevin Perry
Title:	Chief Financial Officer

Date:		August 14, 2006
STATE of Louisiana IN the INTEREST OF A.A.S. and A.M.C.S.

NO. 2018-CJ-1092

Supreme Court of Louisiana.

August 31, 2018

Denied.

HUGHES, J. would grant.
SCPR-24-0000091 

IN THE SUPREME COURT OF THE STATE OF HAWAIʻI 

IN RE YOKO SATO, Petitioner. 

ORIGINAL PROCEEDING 

ORDER GRANTING PETITION TO RESIGN IN GOOD STANDING 

(By: Recktenwald, C.J., McKenna, Eddins, Ginoza, and Devens, JJ.)

 Upon consideration of the petition to resign from the 

practice of law in the State of Hawaiʻi, filed by attorney Yoko 

Sato (Petitioner), pursuant to Rule 1.10 of the Rules of the 

Supreme Court of the State of Hawaiʻi (RSCH), but to retain the 

paper license as a memento, as authorized by RSCH Rule 1.10(b), 

and the declarations submitted in support thereof, we conclude 

that Petitioner has fully complied with the requirements of RSCH 

Rule 1.10. Therefore, 

 IT IS HEREBY ORDERED that the petition to resign is 

granted. Petitioner may retain the paper license as a memento. 

 IT IS FURTHER ORDERED pursuant to RSCH Rule 1.10(g) 

that Petitioner shall comply with the notice, declaration, and 

record requirements of RSCH Rule 2.16(a), (b), (d) and (g). 

Electronically Filed

Supreme Court

SCPR-24-0000091

13-MAR-2024

09:11 AM

Dkt. 6 OGP
2 

 IT IS FURTHER ORDERED that the Clerk shall remove the 

name of Petitioner, attorney number 7192, from the roll of 

attorneys of the State of Hawaiʻi, effective with the filing of 

this order. 

 DATED: Honolulu, Hawaiʻi, March 13, 2024. 

 /s/ Mark E. Recktenwald 

 /s/ Sabrina S. McKenna 

 /s/ Todd W. Eddins 

 /s/ Lisa M. Ginoza 

 /s/ Valdimir P. Devens
I 

114TH CONGRESS 

2D SESSION H. R. 4985 

To amend the Foreign Narcotics Kingpin Designation Act to protect classified 

information in Federal court challenges. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 18, 2016 

Mr. KATKO (for himself and Miss RICE of New York) introduced the following 

bill; which was referred to the Committee on Foreign Affairs, and in addition to the Committee on the Judiciary, for a period to be subsequently 

determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Foreign Narcotics Kingpin Designation Act 

to protect classified information in Federal court challenges. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Kingpin Designation 

5 Improvement Act of 2016’’. 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 4985 IH

1 SEC. 2. PROTECTION OF CLASSIFIED INFORMATION IN 

2 FEDERAL COURT CHALLENGES RELATING TO 

3 DESIGNATIONS UNDER THE NARCOTICS 

4 KINGPIN DESIGNATION ACT. 

5 Section 804 of the Foreign Narcotics Kingpin Des6 ignation Act (21 U.S.C. 1903) is amended by adding at 

7 the end the following: 

8 ‘‘(i) PROTECTION OF CLASSIFIED INFORMATION IN

9 FEDERAL COURT CHALLENGES RELATING TO DESIGNA10 TIONS.—In any judicial review of a determination made 

11 under this section, if the determination was based on clas12 sified information (as defined in section 1(a) of the Classi13 fied Information Procedures Act) such information may 

14 be submitted to the reviewing court ex parte and in cam15 era. This subsection does not confer or imply any right 

16 to judicial review.’’. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS